ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Scopus Q3SCImago #21,671Hybrid

Drugs and Therapy Perspectives

Acronym:drtp
•
Identifier (ISSN):1172-0360(Print)/1179-1977(Online)
•
Publisher:Springer Nature
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
0.6↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Drugs and Therapy Perspectives

WoS Q4
01121.220230.620240.720250.62026
Annual Impact Factor Metric
Current (2026):0.6
Scopus SJR & RankScopus Q3
0.204
#21,671

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
16

16 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
0articles/year
12.77% Gold OA•92% Original Research

Aims & Scope

Drugs & Therapy Perspectives promotes rational pharmacotherapy and effective disease management by publishing concise, authoritative review articles to aid drug formulary and treatment decisions, and original research articles covering all aspects of pharmacological treatment to assist healthcare professionals in providing quality patient care. It focuses on the practical application of research and best evidence for healthcare professionals working in real-world clinical settings. TheJournal includes: Reviews of pharmacological agents, disease management, adverse drug reactions and interactions, or other clinically relevant issues. These provide up-to-date guidance on the use of pharmacological agents in the real-world setting, including step-by-step patient care guidelines to aid treatment decisions, and  the differential features of drugs to enable formulary comparisons.Original research articles with a strong focus on clinical practice and real-world outcomes to assist healthcare professionals in providing quality evidence-based patient care.Therapy-in-practice articles, current opinions and commentaries giving international viewpoints on emerging issues and therapeutic approaches to specific diseases or therapeutic questions. Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drugs & Therapy Perspectives may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.All manuscripts are subject to single-blind peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.

Topics Covered (Recognized by AI)
MedicineInternal medicine87.8%Nursing84.8%Family medicine81.8%Biology80.9%Political science80.4%Law80.4%Pharmacy79.7%Psychology73.4%Psychiatry71.6%Pharmacotherapy60.4%Intensive care medicine56%Pharmacology49.1%Pathology29.1%Genetics27.9%Chemistry24.2%Biochemistry20.2%Surgery20.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

PHARMACOLOGY & PHARMACY

Q4
Rank342/356
IndexESCI
JCIESCI2026

PHARMACOLOGY & PHARMACY

Q4
Rank335/356
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF0.6
Articles / Year48
Total Citations2
2025
IF0.7
Articles / Year86
Total Citations28
2024
IF0.6
Articles / Year86
Total Citations78
2023
IF1.2
Articles / Year64
Total Citations78
2022
IF—
Articles / Year89
Total Citations246

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #21,671Scopus Q3SCImago Profile
Scopus Coverage:1993-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.204

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
0.48

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,450 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations117
3-Year Documents215
Citable Documents204

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology (medical)Q3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Drugs and Therapy Perspectives (acronym: drtp, ISSN: 1172-0360) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Nature in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 0.60, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.204 (Q3), an H-index of 16.

The journal enforces rigorous peer evaluation with a publication frequency of 12 issues per year, an annual output of approximately 0 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,450 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Nature
Publication Language
English
Frequency
12 issues per year
Indexing & Databases
ScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: dd5fe564-c511-41c3-b554-1001e7926391
Database Updated: 2026-09-30